The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells
Open accessAbstract
Therapeutic ex vivo T-cell expansion is limited by low rates and T-cell products of limited functionality. Here we describe a system that mimics natural antigen-presenting cells (APCs) and consists of a fluid lipid bilayer supported by mesoporous silica micro-rods. The lipid bilayer presents membrane-bound cues for T-cell receptor stimulation and costimulation, while the micro-rods enable sustained release of soluble paracrine cues. Using anti-CD3, anti-CD28, and interleukin-2, we show that the APC-mimetic scaffolds (APC-ms) promote two- to tenfold greater polyclonal expansion of primary mouse and human T cells compared with commercial expansion beads (Dynabeads). The efficiency of expansion depends on the density of stimulatory cues and the amount of material in the starting culture. Following a single stimulation, APC-ms enables antigen-specific expansion of rare cytotoxic T-cell subpopulations at a greater magnitude than autologous monocyte-derived dendritic cells after 2 weeks. APC-ms support over fivefold greater expansion of restimulated CD19 CAR-T cells than Dynabeads, with similar efficacy in a xenograft lymphoma model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., & Dustin, M. L. (1999) · Science · doi:10.1126/science.285.5425.221 · Cited by 3,102
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61403-3 · Cited by 2,898
Adoptive cell transfer as personalized immunotherapy for human cancer
Rosenberg, S. A., & Restifo, N. P. (2015) · Science · doi:10.1126/science.aaa4967 · Cited by 2,506
CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Turtle, C. J., Hanafi, L.-A., Berger, C., Gooley, T. A., Cherian, S., Hudecek, M., Sommermeyer, D., Melville, K., Pender, B., Budiarto, T. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85309 · Cited by 2,112
Brentjens, R. J., Rivière, I., Park, J. H., Davila, M. L., Wang, X., Stefanski, J., Taylor, C., Yeh, R., Bartido, S., Borquez-Ojeda, O., et al. (2011) · Blood · doi:10.1182/blood-2011-04-348540 · Cited by 1,286
Rooney, C. M., Smith, C. A., Ng, C. Y. C., Loftin, S. K., Sixbey, J. W., Gan, Y., Srivastava, D.-K., Bowman, L. C., Krance, R. A., Brenner, M. K., et al. (1998) · Blood · doi:10.1182/blood.v92.5.1549 · Cited by 1,135
Engineered T cells: the promise and challenges of cancer immunotherapy
Fesnak, A. D., June, C. H., & Levine, B. L. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.97 · Cited by 1,074
Gattinoni, L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24480 · Cited by 958
Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1
Hunder, N. N., Wallen, H., Cao, J., Hendricks, D. W., Reilly, J. Z., Rodmyre, R., Jungbluth, A., Gnjatic, S., Thompson, J. A., & Yee, C. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800251 · Cited by 911
Imai, C., Mihara, K., Andreansky, M., Nicholson, I. C., Pui, C.-H., Geiger, T. L., & Campana, D. (2004) · Leukemia · doi:10.1038/sj.leu.2403302 · Cited by 840
CD27 is required for generation and long-term maintenance of T cell immunity
Hendriks, J., Gravestein, L. A., Tesselaar, K., van Lier, R. A. W., Schumacher, T. N. M., & Borst, J. (2000) · Nature Immunology · doi:10.1038/80877 · Cited by 779
T-cell-antigen recognition and the immunological synapse
Huppa, J. B., & Davis, M. M. (2003) · Nature Reviews Immunology · doi:10.1038/nri1245 · Cited by 643
The Immunological Synapse Balances T Cell Receptor Signaling and Degradation
Lee, K.-H., Dinner, A. R., Tu, C., Campi, G., Raychaudhuri, S., Varma, R., Sims, T. N., Burack, W. R., Wu, H., Wang, J., et al. (2003) · Science · doi:10.1126/science.1086507 · Cited by 545
Kim, J., Li, W. A., Choi, Y., Lewin, S. A., Verbeke, C. S., Dranoff, G., & Mooney, D. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3071 · Cited by 541
Self-citationMaus, M. V., Thomas, A. K., Leonard, D. G. B., Allman, D., Addya, K., Schlienger, K., Riley, J. L., & June, C. H. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-143 · Cited by 454
Targeting of cancer neoantigens with donor-derived T cell receptor repertoires
Strønen, E., Toebes, M., Kelderman, S., van Buuren, M. M., Yang, W., van Rooij, N., Donia, M., Böschen, M.-L., Lund-Johansen, F., Olweus, J., et al. (2016) · Science · doi:10.1126/science.aaf2288 · Cited by 445
Adoptive cellular therapy: A race to the finish line
June, C. H., Riddell, S. R., & Schumacher, T. N. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3643 · Cited by 403
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cohen, C. J., Gartner, J. J., Horovitz-Fried, M., Shamalov, K., Trebska-McGowan, K., Bliskovsky, V. V., Parkhurst, M. R., Ankri, C., Prickett, T. D., Crystal, J. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82416 · Cited by 374
Hollyman, D., Stefanski, J., Przybylowski, M., Bartido, S., Borquez-Ojeda, O., Taylor, C., Yeh, R., Capacio, V., Olszewska, M., Hosey, J., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318194a6e8 · Cited by 316
Mackensen, A., Meidenbauer, N., Vogl, S., Laumer, M., Berger, J., & Andreesen, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1100 · Cited by 297
Bioorthogonal Copper‐Free Click Chemistry In Vivo for Tumor‐Targeted Delivery of Nanoparticles
Koo, H., Lee, S., Na, J. H., Kim, S. H., Hahn, S. K., Choi, K., Kwon, I. C., Jeong, S. Y., & Kim, K. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201206703 · Cited by 293
Versatile click alginate hydrogels crosslinked via tetrazine–norbornene chemistry
Desai, R. M., Koshy, S. T., Hilderbrand, S. A., Mooney, D. J., & Joshi, N. S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.048 · Cited by 290
Self-citationCollins, M. D., & Keller, S. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702970105 · Cited by 272
Full Activation of the T Cell Receptor Requires Both Clustering and Conformational Changes at CD3
Minguet, S., Swamy, M., Alarcón, B., Luescher, I. F., & Schamel, W. W. A. (2006) · Immunity · doi:10.1016/j.immuni.2006.10.019 · Cited by 259
Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells
Sunshine, J. C., Perica, K., Schneck, J. P., & Green, J. J. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.09.050 · Cited by 244
A carbon nanotube–polymer composite for T-cell therapy
Fadel, T. R., Sharp, F. A., Vudattu, N., Ragheb, R., Garyu, J., Kim, D., Hong, E., Li, N., Haller, G. L., Pfefferle, L. D., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.154 · Cited by 240
Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Eggermont, L. J., Paulis, L. E., Tel, J., & Figdor, C. G. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2014.06.007 · Cited by 217
Li, Y., & Kurlander, R. J. (2010) · Journal of Translational Medicine · doi:10.1186/1479-5876-8-104 · Cited by 207
Steenblock, E. R., & Fahmy, T. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.11 · Cited by 187
Meyer, R. A., Sunshine, J. C., Perica, K., Kosmides, A. K., Aje, K., Schneck, J. P., & Green, J. J. (2015) · Small · doi:10.1002/smll.201402369 · Cited by 183
Kwong, B., Liu, H., & Irvine, D. J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.067 · Cited by 175
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
Wölfl, M., & Greenberg, P. D. (2014) · Nature Protocols · doi:10.1038/nprot.2014.064 · Cited by 154
Perica, K., Bieler, J. G., Schütz, C., Varela, J. C., Douglass, J., Skora, A. D., Chiu, Y., Oelke, M., Kinzler, K. W., Zhou, S., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b02829 · Cited by 153
The immunological synapse: a cause or consequence of T-cell receptor triggering?
Alarcón, B., Mestre, D., & Martínez, N. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03458.x · Cited by 120
Enhanced Cellular Activation with Single Walled Carbon Nanotube Bundles Presenting Antibody Stimuli
Fadel, T. R., Steenblock, E. R., Stern, E., Li, N., Wang, X., Haller, G. L., Pfefferle, L. D., & Fahmy, T. M. (2008) · Nano Letters · doi:10.1021/nl080332i · Cited by 119
Li, A. W., Lu, B., Gu, L., Choi, Y., Kim, J., & Mooney, D. J. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.026 · Cited by 116
Self-citationSteenblock, E. R., Fadel, T. R., Labowsky, M. J., Pober, J. S., & Fahmy, T. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.276329 · Cited by 113
Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy
Turtle, C. J., & Riddell, S. R. (2010) · The Cancer Journal · doi:10.1097/ppo.0b013e3181eb33a6 · Cited by 100
Membrane-Mediated Effect on Ion Channels Induced by the Anesthetic Drug Ketamine
Jerabek, H., Pabst, G., Rappolt, M., & Stockner, T. (2010) · Journal of the American Chemical Society · doi:10.1021/ja910843d · Cited by 87
Zappasodi, R., Nicola, M. D., Carlo‐Stella, C., Mortarini, R., Molla, A., Vegetti, C., Albani, S., Anichini, A., & Gianni, A. M. (2008) · Haematologica · doi:10.3324/haematol.12521 · Cited by 77
Torres, A. J., Contento, R. L., Gordo, S., Wucherpfennig, K. W., & Love, J. C. (2012) · Lab on a Chip · doi:10.1039/c2lc40869d · Cited by 60
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2016) · Blood · doi:10.1182/blood.v128.22.lba-6.lba-6 · Cited by 51
Polymer-Based Synthetic Dendritic Cells for Tailoring Robust and Multifunctional T Cell Responses
Mandal, S., Hammink, R., Tel, J., Eksteen-Akeroyd, Z. H., Rowan, A. E., Blank, K. G., & Figdor, C. G. (2014) · ACS Chemical Biology · doi:10.1021/cb500455g · Cited by 49
Jin, C., Yu, D., Hillerdal, V., Wallgren, A., Karlsson‐Parra, A., & Essand, M. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.1 · Cited by 41
Chauvin, J.-M., Larrieu, P., Sarrabayrouse, G., Prévost‐Blondel, A., Lengagne, R., Desfrançois, J., Labarrière, N., & Jotereau, F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101807 · Cited by 28
Hasan, A. N., & Selvakumar, A. (2015) · Advancements in Genetic Engineering · doi:10.4172/2169-0111.1000130 · Cited by 22
Cited by
Delivery technologies for cancer immunotherapy
Riley, R. S., June, C. H., Langer, R., & Mitchell, M. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0006-z · Cited by 2,607
Cao, H., Duan, L., Zhang, Y., Cao, J., & Zhang, K. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00830-x · Cited by 1,274
Translational Applications of Hydrogels
Correa, S., Grosskopf, A. K., Lopez Hernandez, H., Chan, D., Yu, A. C., Stapleton, L. M., & Appel, E. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01177 · Cited by 1,143
Improving cancer immunotherapy through nanotechnology
Goldberg, M. S. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0186-9 · Cited by 628
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Wang, H., & Mooney, D. J. (2018) · Nature Materials · doi:10.1038/s41563-018-0147-9 · Cited by 467
Self-citation
Metadata
- Authors
- Cheung, A. S., Zhang, D. K. Y., Koshy, S. T., & Mooney, D. J.
- Venue
- Nature Biotechnology
- Published
- 2018-01-15
- Volume
- 36
- Issue
- 2
- Pages
- 160-169
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2783878221
- Cited by
- 372
- References
- 47
- FWCI
- 14.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.